Asgard Therapeutics
is a Swedan-based biotechnology company that researches and develops immunotherapies for the treatment of cancer... Read moreAsgard Therapeutics
is a Swedan-based biotechnology company that researches and develops immunotherapies for the treatment of cancer... Read more
News
May 14, 2026
PharmaTimes
Asgard Therapeutics: Prof Dr Wolfram Brugger
Apr 29, 2026
PharmaTimes
Asgard Therapeutics: Asgard Therapeutics to present new preclinical data on AT108 at ASGCT 2026
Apr 17, 2026
GlobalNewswire
Press Release: Asgard Therapeutics : Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026
Jun 03, 2025
FinanzNachrichten
Asgard Therapeutics: Asgard Therapeutics strengthens its Board of Directors and Advisory Board with leading experts in drug development and cancer immunotherapy
May 15, 2025
PharmaTimes
Asgard Therapeutics: Asgard Therapeutics has appointed Shane Olwill as Chief Development Officer.
Sep 05, 2024
FinanzNachrichten
Asgard Therapeutics: Asgard Therapeutics' study published in Science showing proof-of-concept and strong anti-tumor responses via in vivo cell reprogramming with lead program AT-108
Mar 25, 2024
Global Legal Chronicle
Asgard Therapeutics: Asgard Therapeutics' Financing Round
Mar 15, 2024
BioSpace
Asgard Therapeutics: Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
Nov 09, 2021
privateequitywire
ASGARD THERAPEUTICS: Novo Holdings co-Leads EUR6m seed financing in Asgard Therapeutics
